The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Has the Mathematization of Rheumatoid Arthritis Gone Too Far?

Has the Mathematization of Rheumatoid Arthritis Gone Too Far?

November 12, 2020 • By Carlos Antonio Moura, MD, Ana Luísa Cerqueira de Sant’Ana Costa, MD, & Carlos Geraldo Moura, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The search for knowledge has shaped Western culture and is based on Greek philosophy, especially Aristotelian metaphysics. During the Middle Ages, this knowledge was matured by dialectical scholasticism, culminating, in its later stages, in the amalgam between Islamic science and the neo-Aristotelianism of St. Thomas Aquinas.1 In this way, the foundations of the future scientific method were established, keeping faith and reason intertwined and interdependent.

You Might Also Like
  • Treat Rheumatoid Arthritis to Target
  • Rheumatoid Arthritis Prevention, Remission & Treatment De-Escalation
  • Sex Differences & Rheumatoid Arthritis
Explore This Issue
November 2020

From the 16th century onward, Western science started to reach a progressive protagonism in society, especially through Bacon’s empiricism, Cartesianism, Newtonian mechanics and Darwin’s evolutionism.2 The whole process pointed to the emergence of a new religion, which was baptized by Auguste Comte as positivism. Entering the 20th century, modern science, a lover of mathematical calculations, has received pertinent criticism. When Karl Popper suggested falsifiability theory, instead of verifiability, as the best way for science to obtain evidence, the foundation of evidence-based medicine was laid.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This scientific evidence poses a dilemma: Should all of this knowledge culminate in the art of individualizing the understanding of patients, diseases and their treatments, or should it result in mathematical simplification of samples?

Recognition of RA

In rheumatology, rheumatoid arthritis (RA) is emblematic of this evolution. In 1800, French surgeon Augustin Jacob Landré-Beauvais identified a rheumatism with a phenotype distinct from gout, a previously known disease. British rheumatologist Alfred Baring Garrod called the disease rheumatoid gout in 1859, and his son, Archibald Garrod, in 1890, coined the term rheumatoid arthritis in his book, A Treatise on Rheumatism and Rheumatoid Arthritis.3 Recognition of this new disease made it possible to develop diagnostic strategies, serological research and therapeutic proposals.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In 1937, Erik Waaler discovered that serum of patients with RA caused agglutination in sheep’s blood; this work was replicated in 1948 by Harry Rose, and culminated in the Waaler-Rose test. In 1949, H.C. Coggeshall and colleagues coined the term rheumatoid factor.3,4

The scientific process demands physicians use their expertise to phenotype & individualize the management of our patients instead of mathematizing them.

Also in 1949, the first RA therapeutic criteria were proposed, even though the first diagnostic criteria weren’t developed until 1956.5,6 The criteria were focused on staging, functionality and post-treatment disease activity, including erythrocyte sedimentation rate, signs and symptoms, radiographic progression, etc. They laid the foundation for the first RA clinical remission criteria, established in 1982.7 Following advances in research and statistical methodologies, these criteria would be refined in the 1990s, with the determination of funcional status and DAS28 score, both calculable like many algebraic equations.8,9

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

At the beginning of the 21st century, the treat-to-target strategy was established in RA and was adopted for other rheumatic diseases.10 Although we know a specific target should exist, the question remains: What is the best way to measure success in reaching the target?

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Opinion, Rheumatoid Arthritis Tagged With: Classification Criteria, evidence-based medicine, Speak Out RheumatologyIssue: November 2020

You Might Also Like:
  • Treat Rheumatoid Arthritis to Target
  • Rheumatoid Arthritis Prevention, Remission & Treatment De-Escalation
  • Sex Differences & Rheumatoid Arthritis
  • Depression & Anxiety Linked to Poor Rheumatoid Arthritis Outcomes

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.